Skip to main content
. 2018 Aug 6;19(8):2306. doi: 10.3390/ijms19082306
FDA Food and Drug Administration
CVDs Cardiovascular diseases
ELIS Enzyme linked immunosorbent assay
PGE1 Prostaglandin E1
HEPES [N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid]
PRP Platelet-rich plasma
IgG Immunoglobulin G
BSA Albumin bovine serum
PE P-phycoerythrin
FITC Fluorescein isothiocyanate
HPLC High performance liquid chromatography
ESI Electrospray ionization
SRM Selected reaction monitoring
VWF Von Willebrand factor
PCI Percutaneous coronary intervention